Brian Van Dyke

Title: Brian Van Dyke: Innovator in Kappa Opioid Receptor Antagonism

Introduction

Brian Van Dyke is a notable inventor based in Hightstown, NJ (US). He has made significant contributions to the field of pharmacology, particularly in the development of kappa opioid receptor antagonists. His innovative work has led to the creation of a unique crystalline salt form that holds promise for various therapeutic applications.

Latest Patents

Brian Van Dyke holds 1 patent for his invention titled "Crystalline salt forms of kappa opioid receptor antagonist and products and methods related thereto." This patent discloses a solid Form A of a specific compound, which exhibits distinct X-ray diffraction patterns. The solid Form A is recognized as an antagonist of the kappa-opioid receptor (KOR) and is useful for treating conditions that benefit from such antagonism. The patent also includes compositions comprising the solid Form A and related methods of use.

Career Highlights

Brian Van Dyke is currently associated with Neumora Therapeutics, Inc., where he continues to advance his research and development efforts. His work focuses on innovative solutions in the pharmaceutical industry, particularly in the realm of opioid receptor modulation.

Collaborations

Throughout his career, Brian has collaborated with talented individuals such as Yawei Shi and Mengya Ma. These collaborations have contributed to the success of his research and the advancement of his inventions.

Conclusion

Brian Van Dyke is a distinguished inventor whose work in kappa opioid receptor antagonism has the potential to impact therapeutic practices significantly. His innovative contributions continue to shape the future of pharmacological research and development.